Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimicrobial effect of amniotic fluid.

H Thadepalli, V T Bach, E C Davidson

    Obstetrics and Gynecology
    |August 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Amniotic fluid (AF) from early pregnancy showed minimal antimicrobial activity, while late-term AF strongly inhibited anaerobic bacteria. This difference may explain increased anaerobic infections during the third trimester.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Efficacy of telithromycin in the treatment of experimental Bacteroides fragilis intraabdominal abscess in the senescent mice.

    Le infezioni in medicina·2004
    Same author

    Highlights of the 14th Annual Scientific Meeting of the Association for Academic Minority Physicians, 2000.

    Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians·2002
    Same author

    Bacteroides fragilis-induced intra-abdominal abscess in an experimental model treated with telithromycin (HMR 3647).

    Chemotherapy·2000
    Same author

    Salmonella typhimurium-induced reactivation of latent HIV-1 in promonocytic U1 cells is inhibited by trovafloxacin.

    International journal of molecular medicine·2000
    Same author

    Evaluation of trovafloxacin in the treatment of Klebsiella pneumoniae lung infection in tumour-bearing mice.

    The Journal of antimicrobial chemotherapy·2000
    Same author

    Preventing perinatal transmission of human immunodeficiency virus in the United States. Committee on Perinatal Transmission of HIV.

    Obstetrics and gynecology·1999
    Same journal

    The Political Determinants of Obstetric Prescribing.

    Obstetrics and gynecology·2026
    Same journal

    Glucagon-Like Peptide-1 Receptor Agonists and Risk of Adverse Maternal Pregnancy Outcomes: A Systematic Review and Meta-analysis.

    Obstetrics and gynecology·2026
    Same journal

    Milestones in Motion: Vaginal Birth After Cesarean.

    Obstetrics and gynecology·2026
    Same journal

    Ebola Virus in Pregnancy.

    Obstetrics and gynecology·2026
    Same journal

    A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth.

    Obstetrics and gynecology·2026
    Same journal

    The Effects of Climate Change on Obstetric and Gynecologic Health.

    Obstetrics and gynecology·2026
    See all related articles

    Area of Science:

    • Obstetrics and Gynecology
    • Microbiology
    • Infectious Diseases

    Background:

    • Amniotic fluid (AF) plays a crucial role in fetal development and protection.
    • The antimicrobial properties of AF may vary throughout pregnancy.
    • Anaerobic bacterial infections are a concern during pregnancy and postpartum.

    Purpose of the Study:

    • To compare the antimicrobial effects of AF from the first (AF1), second (AF2), and third (AF3) trimesters.
    • To assess the inhibitory activity of AF against specific anaerobic bacteria and a Gram-negative aerobic bacterium.

    Main Methods:

    • Bacterial strains including Bacteroides fragilis, Eubacterium lentum, Peptostreptococcus anaerobius, and Escherichia coli were used.
    • The growth of these bacteria was monitored in AF samples obtained during different trimesters over a 24-hour period.

    Related Experiment Videos

    Main Results:

    • AF1 supported the growth of most tested anaerobes for 24 hours.
    • AF2 temporarily inhibited Peptostreptococcus anaerobius and Eubacterium lentum but supported Escherichia coli and Bacteroides fragilis growth.
    • AF3 demonstrated significant antimicrobial activity, inhibiting all tested bacteria for at least 8 hours.

    Conclusions:

    • Amniotic fluid exhibits increasing antimicrobial efficacy against anaerobic bacteria as pregnancy progresses.
    • The limited antimicrobial effect of early-trimester AF may contribute to a higher incidence of anaerobic infections during the third trimester compared to the prenatal period.